CURE PHARMA HOLDING CORP COM (AVRW)
Institutional ownership reported to the SEC as of Q2 2023, across 18 quarters.
1
Reporting holders
$16.1K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Sandhill Capital Partners LLC | $16.1K | 150,000 | 0.00% | 18q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | $16.1K | 150,000 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $21.0K | 150,000 | 0 | 1 | 0 | 0.0% |
| Q4 2022 | 2 | $29.4K | 187,020 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 2 | $48.0K | 187,020 | 0 | 0 | 0 | 0.0% |
| Q2 2022 | 2 | $48.0K | 187,020 | 0 | 1 | 0 | 0.0% |
| Q1 2022 | 2 | $43.0K | 162,020 | 0 | 0 | 1 | 0.0% |
| Q4 2021 | 2 | $68.0K | 187,020 | 0 | 1 | 0 | 0.0% |
| Q3 2021 | 2 | $114.0K | 156,520 | 0 | 0 | 1 | 0.0% |
| Q2 2021 | 3 | $98.0K | 191,520 | 0 | 1 | 0 | 0.0% |
| Q1 2021 | 2 | $125.0K | 136,520 | 0 | 1 | 0 | 0.0% |
| Q4 2020 | 2 | $92.0K | 70,520 | 0 | 1 | 0 | 0.0% |
| Q3 2020 | 2 | $95.0K | 67,500 | 1 | 0 | 0 | 0.0% |
| Q2 2020 | 1 | $18.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q1 2020 | 1 | $21.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q4 2019 | 1 | $30.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q3 2019 | 1 | $40.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q2 2019 | 1 | $52.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q1 2019 | 2 | $45.0K | 10,200 | 1 | 0 | 0 | 0.0% |